Danicopan Uses, Dosage, Side Effects and more
Danicopan is under investigation in clinical trial NCT03459443 (A Proof of Concept Study for a 12 Month Treatment in Patients With C3 Glomerulopathy (C3G) or Immune-Complex Membranoproliferative Glomerulonephritis (IC-MPGN)).
| Trade Name | Danicopan |
| Generic | Danicopan |
| Danicopan Other Names | Danicopan |
| Type | |
| Formula | C26H23BrFN7O3 |
| Weight | Average: 580.418 Monoisotopic: 579.102979 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
